Brand Ozempic retails at $998/month. Compounded semaglutide — the same active molecule — costs $99-$199/month from a licensed US telehealth pharmacy. If your insurance just dropped semaglutide coverage or you were paying cash, switching saves $700-$900/month with no clinical compromise on dose, frequency, or efficacy. The 6 programs that ship reliably in June 2026: TrimRx at $199/mo (Editor's Choice), Yucca Health at $146/mo, MyStart Health at $224/mo with code, MEDVi at $179 first month, Embody at $99/mo (cheapest), and SkinnyRx at $199/mo. Below: the exact dose conversion, the timing trick to switch mid-cycle, what to do with leftover Ozempic, and when NOT to switch.
Should you switch from Ozempic to compounded semaglutide?
Yes, if any of these apply: - Your insurance dropped semaglutide coverage in 2025 or 2026 (millions did — see our 24M lost coverage report) - You were paying cash retail ($700-$1,000/mo) for Ozempic off-label for weight loss - Your Ozempic savings card maxed out at 12 fills and you're now at full copay - You're on Medicare Part D and don't qualify for the July 1 $50/mo bridge
No, wait, or rethink, if: - You have a Type 2 diabetes diagnosis AND commercial insurance — your Ozempic copay is likely $25-$50/month and that's already cheaper than compounded - You qualify for Medicare's $50/month GLP-1 bridge starting July 1, 2026 (BMI ≥30, Part D) — wait the 25 days - You're within 2 weeks of a planned dose escalation — finish that cycle on Ozempic first - You have pancreatitis, gallbladder disease, or thyroid C-cell tumor history — the compounded path uses the same molecule and same risks; talk to your prescriber
The cost math: why switching saves $700+/month
| What you pay for Ozempic | Monthly cost | |---|---| | Cash retail (no insurance / off-label) | $998-$1,089/mo | | Insured copay (Type 2 diabetes, commercial) | $25-$50/mo | | Insured copay (no T2D, dropped coverage) | Full retail or denied | | Ozempic Savings Card (T2D, commercial, max 12 fills) | $25/mo |
| What you'd pay for compounded semaglutide | Monthly cost | |---|---| | Embody (cheapest legit) | $99/mo | | Yucca Health (6-month plan) | $146/mo | | MEDVi (first month promo) | $179/mo | | TrimRx (Editor's Choice, flat) | $199/mo | | SkinnyRx | $199/mo | | MyStart Health (with code SELFLOVE25) | $224/mo |
Net savings if you were paying cash retail: $799-$990/month, or $9,600-$11,880/year. Net savings if your insurance just dropped you: the difference between full retail ($998+) and $99-$224, which is also in the $700-$900/month range.
Dose conversion: Ozempic → compounded semaglutide
The active molecule is identical (semaglutide). The dose conversion is 1:1 by milligram. You stay on the exact mg you were on with Ozempic — no titration restart needed if the new provider continues your existing dose.
| Your Ozempic dose | Switch to compounded at | |---|---| | 0.25 mg / week (starting) | 0.25 mg / week | | 0.5 mg / week | 0.5 mg / week | | 1.0 mg / week | 1.0 mg / week | | 1.7 mg / week | 1.7 mg / week | | 2.0 mg / week (max) | 2.0 mg / week | | 2.4 mg / week (Wegovy-equivalent) | 2.4 mg / week |
Important nuance: Compounded semaglutide is dispensed as a multi-dose vial measured in mg per mL (usually 2.5 mg/mL or 5 mg/mL). You'll draw your dose with a small insulin syringe rather than clicking a pre-filled pen. Every legitimate program ships with syringes, alcohol wipes, and a dose chart. The first injection is the only awkward part — by week two it's routine.
Programs that handle dose continuity best: TrimRx and MyStart Health — both have intake forms that explicitly ask your current Ozempic dose and prescribe the matching compounded dose without restarting titration. Yucca Health does this too on the clinician call.
The 6 programs ranked for switchers
1. TrimRx — $199/month (Editor's Choice for switchers)
TrimRx ("Jrnys") is the cleanest switch experience: $199/month flat covers medication at any dose, no surprise charges when you continue at 1.0mg or 2.4mg. The intake form has a dedicated "currently taking Ozempic" path that skips the titration restart most programs default to.
Switch-friendly because: Flat pricing at all doses (some programs charge 30-50% more at higher doses); explicit continuity from brand prescriptions; 5-7 day shipping; LegitScript-listed 503B pharmacy.
2. Yucca Health — $146/month on 6-month plan
Yucca (PeterMD) is the cheapest among tracked programs with full credentialing. The 6-month commitment is the catch — it's not refundable past day 14 — but Klarna/Affirm/Afterpay financing lets you spread the upfront cost. For a high-conviction switcher who's already on a stable dose, this is the lowest total cost.
Switch-friendly because: Real clinician call on intake (they confirm your existing Ozempic dose and continue it); 503B outsourcing facility; financing available.
3. MyStart Health — $224/month with code SELFLOVE25
MyStart's headline rate is $299/month but the SELFLOVE25 code knocks 25% off. What you actually get for $224: unlimited clinician access, labs included, and a brand-pathway upgrade if you ever want to switch back to Ozempic or Wegovy. For switchers who anticipate side-effect questions or dose changes, the unlimited messaging access is genuinely useful.
Switch-friendly because: Unlimited messaging access (most programs gate this to 1-2 messages per month); labs included so you can verify A1C and lipid panels mid-switch.
4. MEDVi — $179 first month, $299 refills
MEDVi has the lowest first-month entry point of any tracked program: $179. If you're risk-averse about switching and want to test compounded semaglutide for one month before committing to the longer-term $299/month rate, this is the lowest-friction starting point.
Switch-friendly because: Low first-month cost lets you test the compounded experience risk-free; same 503B pharmacy tier as TrimRx and Yucca.
5. Embody — $99/month (cheapest legit)
Embody is the cheapest credentialed compounded GLP-1 program at $99/month for injections. For a pure cost-driven switch — you know compounded works and you want the lowest monthly bill — Embody is the floor.
Switch-friendly because: Lowest ongoing cost (literally 1/10th of Ozempic retail); HSA/FSA eligible; oral GLP-1 gum option for needle-averse switchers.
Worth knowing: Embody's $99 covers a starting dose; if you were on Ozempic 1.0mg+ and need to continue at that dose, ask their intake about higher-dose pricing during the call.
6. SkinnyRx — $199/month
SkinnyRx prices semaglutide at $199/month flat. No promo codes needed, no 6-month commitment, no first-month discount. If you want a TrimRx-priced alternative without the brand recognition, SkinnyRx is a credible same-tier option.
Switch-friendly because: No commitment; flat $199 at all doses; multi-format options (injection, drops, lozenges) if you want to experiment with delivery methods.
Step-by-step: how to actually switch this month
Day 0 — Order your last Ozempic refill (don't skip it). You want overlap, not a gap. If your insurance just dropped coverage, fill any final approved scripts. If you're cash-pay, pick up enough to cover the 7-14 days between today and your first compounded shipment.
Day 1 — Pick a program, complete intake. TrimRx, Yucca Health, and MyStart Health all run intake same-day. Be specific about your current Ozempic dose (mg) and the date of your last shot. The clinician will write a continuation prescription, not a starter dose.
Day 2-3 — Prescription transmitted to compounding pharmacy. This is the fastest leg. 503B outsourcing pharmacies queue compounded doses in batches; expect compounding to start within 24-48 hours of clinician approval.
Day 5-10 — Compounded shipment arrives. Refrigerated, multi-dose vial, syringes, alcohol wipes, dose chart. Verify the mg/mL concentration matches what the clinician told you.
Day 7 (or your next scheduled Ozempic day) — Take your first compounded dose. Draw the exact mg you'd have injected from your Ozempic pen. Same day of week. Same injection site rotation (abdomen, thigh, upper arm). The drug is identical — the only thing changing is the dispensing format.
Day 14 — Check in. Most programs prompt a 14-day follow-up. Side effects should match your prior Ozempic experience (nausea, mild GI). If they're meaningfully worse, message your prescriber — sometimes the inactive ingredients (B12, glycine) in compounded formulations cause mild differences.
What to do with leftover Ozempic pens
If you stop Ozempic mid-pen, you have ~3-4 doses left in the pen at any given dose. Two options:
1. Use them. Pens are stable refrigerated. You can finish the pen on the same week-of-the-week schedule, then start compounded the following week. This is the lowest-waste path. 2. Don't gift, sell, or share. Federal law prohibits transferring prescription medications. Local pharmacy take-back programs accept unused pens.
If your final Ozempic dose was the same mg as your compounded prescription, you can run them in parallel during the transition week — finish the pen on its normal day, take compounded the following week. Don't double-dose.
Red flags: when NOT to switch
- The program won't show their pharmacy's name. Legitimate programs name the 503A or 503B partner. If they dodge, walk away.
- No LegitScript verification. Most tracked programs are LegitScript-listed. Cross-check at legitscript.com before paying.
- Pricing more than $249/month for compounded semaglutide alone. That's the ceiling for legitimate cash-pay compounded sema in June 2026. Higher prices usually mean the program is bundling clinical fees, but it's also a margin signal.
- Pre-payment longer than 6 months. Programs asking for 12-month upfront are a financial-risk red flag, even if they're licensed. Compounding regulations could shift (see our update on the FDA personalized formulation rule).
- Generic "doctor on call" with no name or NPI. Every legitimate telehealth prescriber has a verifiable NPI number. Ask. They should provide it without resistance.
A note about July 1, 2026 (Medicare bridge)
If you're on Medicare Part D and have a BMI of 30+, the federal $50/month GLP-1 bridge program starts July 1, 2026 — 25 days from today. It covers brand Wegovy at $50/month flat. For Medicare-eligible patients who specifically qualify, this beats every compounded option on price.
Who qualifies for the $50/mo bridge: - Medicare Part D enrollee - BMI ≥30 OR BMI ≥27 with weight-related comorbidity (T2D, hypertension, sleep apnea, dyslipidemia) - Prescription from any Medicare-credentialed prescriber
Who doesn't qualify: - Medicare Advantage plans that don't include Part D - Medicaid-only (separate program in each state — see our Medicaid coverage tracker for state-by-state details) - Commercial insurance enrollees (use the Wegovy NovoCare $249/mo program instead) - Anyone without a documented BMI in their Medicare record
If you're 60+, on Medicare Part D, and have been paying for Ozempic out of pocket — wait 25 days. If you're cash-pay under 65 or your insurance dropped you, the switch math doesn't change: compounded semaglutide at $99-$224/month wins.
FAQ
Will I lose weight-loss progress switching? No. Same molecule, same dose, same dosing schedule. The half-life of semaglutide is ~1 week. Switching the dispensing format mid-cycle (Ozempic pen → compounded vial) has no clinical effect on continuity.
Can I switch directly from Wegovy instead of Ozempic? Yes. Wegovy is the same molecule (semaglutide) approved specifically for obesity at higher doses (up to 2.4mg/week). The compounded path covers all Wegovy doses. The conversion is identical — match the mg.
Do I need to tell my primary care doctor? You should. Compounded semaglutide is a prescription medication; documenting the switch in your primary chart prevents drug-interaction issues if you need labs, surgery, or are prescribed other medications later. Most telehealth programs will fax records on request.
What if the FDA pulls compounded semaglutide off the market? The FDA removed semaglutide from the official shortage list in February 2025; pharmacies pivoted to "personalized formulations" (most add B12 or glycine) which remain legal under 503A/503B compounding rules. If that loophole closes in 2026 or 2027, your fallback paths: brand Wegovy at $249/mo via NovoCare, brand Ozempic at $25/mo if you have T2D + commercial insurance, or switching molecules entirely to compounded tirzepatide or oral Foundayo at $149/mo.
Is compounded semaglutide as effective as Ozempic in real-world data? The active molecule is identical. Clinical effectiveness depends on dose, adherence, and individual response — not on whether the pharmacy is Novo Nordisk or a 503B compounder. Real-world adherence is actually higher on compounded programs because the cost barrier is lower.
For the full provider comparison see our cheapest compounded semaglutide ranking and the cheapest GLP-1 programs page. For the long-term cardiovascular and kidney case for continuing GLP-1 therapy after switching, see our Ozempic long-term safety post.